Filing Flows › Orthopediatrics (KIDS) › Q2 2026 › vs Q1 2026
Orthopediatrics (KIDS) Q2 2026 vs Q1 2026 (quarter over quarter)
Orthopediatrics's revenue rose $11.1M (+19%) from $59.4M in Q1 2026 to $70.5M in Q2 2026. The biggest changes: Trauma and deformity +$9.6M (+22%); Scoliosis +$1.4M (+9%); Sports medicine/other +$125K (+14%).
Orthopediatrics, Q2 2026: revenue $70.5M (+15% year over year), operating margin -5.8%, net loss $7.2M, operating cash flow $928K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Trauma and deformity | $52.6M | $43.0M | $9.6M | +22% |
| Scoliosis | $16.9M | $15.4M | $1.4M | +9% |
| Sports medicine/other | $1.0M | $875K | $125K | +14% |
| Revenue | $70.5M | $59.4M | $11.1M | +19% |
| Net loss | $7.2M | $10.7M | −$3.5M | -33% |
| Costs & expenses | $77.7M | $70.2M | $7.5M | +11% |
| Operating costs | $74.6M | $67.7M | $6.9M | +10% |
| Interest & other, net | $2.9M | $2.5M | $338K | +13% |
| Income tax | $234K | −$171K | $405K | — |
| Cost of revenue | $18.1M | $16.0M | $2.2M | +14% |
| Research & development | $2.3M | $2.2M | $94K | +4% |
| Sales & marketing | $21.3M | $18.5M | $2.8M | +15% |
| General & admin | $32.8M | $31.0M | $1.8M | +6% |
| Operating cash sources | $9.9M | $9.7M | $194K | +2% |
| Depreciation & amortization | $5.7M | $5.7M | −$15K | -0.3% |
| Share-based compensation | $4.2M | $4.0M | $209K | +5% |
| Net loss absorbed | $7.2M | $10.7M | −$3.5M | -33% |
| Working capital & other | $1.8M | $2.3M | −$497K | -22% |
| Operating cash flow | $928K | −$3.3M | $4.2M | — |
| Capital expenditures | $4.0M | $1.8M | $2.3M | +130% |
| Negative free cash flow (OCF − capex) | $3.1M | $5.0M | −$1.9M | -38% |
Questions
How much did Orthopediatrics's revenue grow quarter over quarter in Q2 2026?
Orthopediatrics's revenue rose $11.1M (+19%) from $59.4M in Q1 2026 to $70.5M in Q2 2026.
What drove Orthopediatrics's revenue change in Q2 2026?
Trauma and deformity +$9.6M (+22%); Scoliosis +$1.4M (+9%); Sports medicine/other +$125K (+14%).